VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $43,655,000 | -66.1% | 196,511 | -69.7% | 1.10% | -68.9% |
| Q1 2015 | $128,913,000 | -28.5% | 649,042 | -48.5% | 3.55% | -15.6% |
| Q4 2014 | $180,409,000 | -16.7% | 1,260,633 | -23.6% | 4.21% | -15.5% |
| Q3 2014 | $216,623,000 | +64.8% | 1,651,090 | +58.4% | 4.99% | +89.7% |
| Q2 2014 | $131,469,000 | +23.2% | 1,042,410 | +28.7% | 2.63% | +35.9% |
| Q1 2014 | $106,748,000 | +1363.1% | 809,743 | +1202.9% | 1.94% | +1216.3% |
| Q4 2013 | $7,296,000 | +12.2% | 62,148 | -0.3% | 0.15% | -6.4% |
| Q3 2013 | $6,501,000 | -73.9% | 62,308 | -78.4% | 0.16% | -69.6% |
| Q2 2013 | $24,884,000 | +193.2% | 289,077 | +155.5% | 0.52% | +84.0% |
| Q1 2013 | $8,487,000 | – | 113,134 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |